PYC Therapeutics Ltd (PYC) — Cash Flow Reinvestment Rate

Latest as of June 2017: 0.00x

PYC Therapeutics Ltd (PYC) has a Cash Flow Reinvestment Rate of 0.00x as of June 2017, reinvesting AU$608.00 (capex AU$608.00 ) from operating cash flow of AU$1.73 Million. Explore how efficiently does PYC Therapeutics Ltd generate cash to assess how effectively this company generates cash.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

AU$608.00

Capex + Investments

Operating Cash Flow

AU$1.73 Million

AUD

Capital Expenditures

AU$608.00

AUD

PYC Therapeutics Ltd Cash Flow Reinvestment Rate (2004–2004)

Historical reinvestment intensity for PYC Therapeutics Ltd across 1 annual periods. Explore investment intensity of PYC Therapeutics Ltd to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for PYC Therapeutics Ltd (2004–2004)

Year-by-year capital reinvestment analysis for PYC Therapeutics Ltd. For live market cap and broader valuation context, see PYC Therapeutics Ltd (PYC) market capitalisation.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2004	0.11x	AU$3.00K	AU$28.00K	AU$3.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow